IGMPI facebook News
IGMPI Logo
इंस्टीट्यूट ऑफ गुड मैन्यूफैक्चरिंग प्रैक्टिसेज इंडिया
Institute of Good Manufacturing Practices India

(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)

ADMISSIONS NOTICE
18001031071 (Toll Free), +91 11 26512850
Regular Classroom | Online Mode
Lexogen launches LUTHOR HD Pool high-throughput single-cell RNA-Seq kit and LUTHOR single cell dispenser.
Medtronic collaborates with Siemens Healthineers for spine surgery tech
FDA planning to reclassify hepatitis B assays
Indian Cancer Genome Atlas introduces the country?s first comprehensive cancer multi-omics data portal
Substituting ultra-processed foods in diet lowers type 2 diabetes risk
WHO and partners to aim for urgent, high-level action to address global distress of antimicrobial resistance
EU drug regulator authorise use of Bavarian Nordic's mpox vaccine, Imvanex for adolescents
Chronic diseases result into hidden epidemic of hearing loss in India, cautions experts
India?s pandemic preparedness supports implement robust strategy to manage Mpox outbreak
Indian healthcare emphasizes digital transformation intensify requirement for data security
Indian healthcare emphasizes digital transformation intensify requirement for data security
Indian hospitals capitalizing on Union govt?s Heal in India Mission to stimulate home healthcare options
Indian hospitals capitalizing on Union govt?s Heal in India Mission to stimulate home healthcare options
Maharashtra FDA took strict action against ayurvedic drug manufacturer for violating DMR Act
Maharashtra FDA took strict action against ayurvedic drug manufacturer for violating DMR Act
Roche reports phase III CENTERSTONE study of Xofluza significantly decreases the transmission of influenza viruses
Phase 1 trial of DS-9606 states promising preliminary clinical activity in advanced solid tumours patients
Pivotal phase-III FIBRONEER-IPF study of nerandomilast meets primary endpoint : Boehringer Ingelheim